Results 11 to 20 of about 366,425 (301)

SPECIFIC IMMUNOGLOBULINS FOR INTRAVENOUS INJECTION IN PEDIATRIC PRACTICES

open access: yesПедиатрическая фармакология, 2007
The article presents information on the protective and therapeutic efficiency of specific immunoglobulins for intravenous injection. The author gives a characteristics and provides regimes of medication dosage of specific immunoglobulins for intravenous ...
A.L. Zaplatnikov
doaj   +4 more sources

Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice. [PDF]

open access: yesMol Ther
Shiga toxin-producing Escherichia coli (STEC) causes hemorrhagic colitis, hemolytic uremic syndrome, and acute encephalopathies that may lead to sudden death or severe neurologic sequelae.
Ozuru R   +21 more
europepmc   +2 more sources

Iodinated contrast media and cerebral hemorrhage after intravenous thrombolysis [PDF]

open access: yes, 2011
<p>Background and Purpose: Iodinated contrast is increasingly used in CT perfusion or angiographic examinations in acute stroke. Increased risk of intracranial hemorrhage (ICH) complicating microcatheter contrast injections has recently been ...
McVerry, F.   +11 more
core   +1 more source

The extent of injection site infection in injecting drug users: findings from a national surveillance study. [PDF]

open access: yes, 2010
Injection site infections in injecting drug users (IDUs) are associated with serious morbidity and healthcare costs. Factors associated with symptoms of these were examined through annual (2006-2008) unlinked-anonymous survey of IDUs in England, Wales ...
Marongiu, A   +3 more
core   +1 more source

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. [PDF]

open access: yes, 2008
BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America.
Ncube, F   +9 more
core   +1 more source

Clinical trial to compare safety and tolerability between intravenous infusion and bolus intravenous injection of ApTOLL in healthy volunteers. [PDF]

open access: yesMol Ther Nucleic Acids
ApTOLL, a new modulator of Toll-like receptor 4, has demonstrated safety and efficacy in healthy subjects and in stroke patients; however, the route of administration used so far (30 min infusion) can potentially be an issue in the acute stroke units ...
Hernández-Jiménez M   +8 more
europepmc   +2 more sources

Immediate-Type Hypersensitivity to Succinylated Corticosteroids [PDF]

open access: yes, 2010
Background: Despite their frequent use, systemic corticosteroids have rarely elicited immediate-type reactions. Objective: We report two male patients, aged 26 and 70 years, respectively, with severe immediate-type hypersensitivity secondary to the ...
Raewer, Helen-Caroline   +7 more
core   +1 more source

DETERMINATION OF GENTAMICIN SULFATE IN PLASMA AND SYNOVIAL FLUID OF DONKEYS FOLLOWING ITS ADMINISTRATION [PDF]

open access: yesAssiut Veterinary Medical Journal, 1992
The concentrations of gentamicin sulfate in plasma and synovial fluid oc clinically healthy adult donkeys were measured periodically for 24 hours on twenty one donkeys after the intravenous and/or the intra articular administration of the drug.
SAMIA M. SELEIM   +3 more
doaj   +1 more source

Initial experience with use of infrared assistance for intravenous injection of radiopharmaceuticals

open access: yesWorld Journal of Nuclear Medicine, 2021
Radiopharmaceutical injection is challenging as it poses radiation exposure to staff as well as patient. Infrared light-assisted devices have been available since many years and have garnered mixed reviews in the pediatric age group.
Ashok Kumar   +6 more
doaj   +1 more source

RNA-Seq Based Toxicity Analysis of Mesoporous Polydopamine Nanoparticles in Mice Following Different Exposure Routes

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Mesoporous polydopamine nanoparticles (MPDA NPs) are promising nanomaterials that have the prospect of clinical application for multi-strategy antitumor therapy, while the biosecurity of MPDA NPs remains indistinct.
Zihua Huang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy